News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
385,219 Results
Type
Article (18739)
Company Profile (289)
Press Release (366191)
Multimedia
Podcasts (51)
Webinars (8)
Section
Business (111650)
Career Advice (438)
Deals (21573)
Drug Delivery (54)
Drug Development (61745)
Employer Resources (52)
FDA (9345)
Job Trends (7643)
News (202421)
Policy (16956)
Tag
Academia (1265)
Accelerated approval (4)
Adcomms (15)
Allergies (68)
Alliances (28566)
ALS (79)
Alzheimer's disease (1104)
Antibody-drug conjugate (ADC) (111)
Approvals (9365)
Artificial intelligence (183)
Autoimmune disease (22)
Automation (8)
Bankruptcy (199)
Best Places to Work (6782)
BIOSECURE Act (7)
Biosimilars (52)
Biotechnology (238)
Bladder cancer (72)
Brain cancer (23)
Breast cancer (214)
Cancer (1855)
Cardiovascular disease (146)
Career advice (384)
Career pathing (5)
CAR-T (141)
Cell therapy (385)
Cervical cancer (15)
Clinical research (50752)
Collaboration (671)
Compensation (309)
Complete response letters (18)
COVID-19 (1416)
CRISPR (45)
C-suite (194)
Cystic fibrosis (91)
Data (1975)
Denatured (12)
Depression (40)
Diabetes (199)
Diagnostics (3092)
Digital health (7)
Diversity (2)
Diversity, equity & inclusion (18)
Drug discovery (98)
Drug pricing (63)
Drug shortages (17)
Duchenne muscular dystrophy (95)
Earnings (48096)
Editorial (30)
Employer branding (5)
Employer resources (46)
Events (62621)
Executive appointments (543)
FDA (10417)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (605)
Gene editing (106)
Generative AI (15)
Gene therapy (284)
GLP-1 (460)
Government (1963)
Grass and pollen (3)
Guidances (126)
Healthcare (9847)
Huntington's disease (23)
IgA nephropathy (26)
Immunology and inflammation (107)
Indications (24)
Infectious disease (1513)
Inflammatory bowel disease (129)
Inflation Reduction Act (10)
Influenza (32)
Intellectual property (83)
Interviews (63)
IPO (11503)
IRA (25)
Job creations (1236)
Job search strategy (339)
Kidney cancer (8)
Labor market (13)
Layoffs (238)
Leadership (7)
Legal (2943)
Liver cancer (52)
Lung cancer (247)
Lymphoma (121)
Machine learning (7)
Management (12)
Manufacturing (200)
MASH (63)
Medical device (6276)
Medtech (6278)
Mergers & acquisitions (10582)
Metabolic disorders (530)
Multiple sclerosis (71)
NASH (14)
Neurodegenerative disease (77)
Neuropsychiatric disorders (26)
Neuroscience (1576)
NextGen: Class of 2025 (2956)
Non-profit (1392)
Now hiring (22)
Obesity (271)
Opinion (146)
Ovarian cancer (74)
Pain (71)
Pancreatic cancer (73)
Parkinson's disease (130)
Partnered (10)
Patents (186)
Patient recruitment (100)
Peanut (40)
People (32109)
Pharmaceutical (50)
Pharmacy benefit managers (12)
Phase I (16950)
Phase II (23059)
Phase III (15870)
Pipeline (1174)
Policy (77)
Postmarket research (1272)
Preclinical (6962)
Press Release (36)
Prostate cancer (86)
Psychedelics (35)
Radiopharmaceuticals (230)
Rare diseases (341)
Real estate (2128)
Recruiting (19)
Regulatory (13561)
Reports (20)
Research institute (1213)
Resumes & cover letters (58)
Rett syndrome (5)
RNA editing (5)
RSV (24)
Schizophrenia (65)
Series A (116)
Series B (75)
Service/supplier (2)
Sickle cell disease (49)
Special edition (12)
Spinal muscular atrophy (124)
Sponsored (23)
Startups (2252)
State (1)
Stomach cancer (8)
Supply chain (40)
Tariffs (16)
The Weekly (38)
Vaccines (326)
Venture capitalists (35)
Weight loss (157)
Women's health (17)
Worklife (5)
Date
Last 7 days (762)
Last 30 days (2279)
Last 365 days (25052)
2025 (8960)
2024 (27027)
2023 (29940)
2022 (36110)
2021 (38021)
2020 (34000)
2019 (24006)
2018 (17755)
2017 (19632)
2016 (17026)
2015 (20753)
2014 (15145)
2013 (11201)
2012 (11470)
2011 (12023)
2010 (11391)
Location
Africa (294)
Alabama (46)
Alaska (3)
Arizona (99)
Arkansas (8)
Asia (26541)
Australia (5693)
California (4989)
Canada (1681)
China (440)
Colorado (193)
Connecticut (222)
Delaware (127)
Europe (51586)
Florida (694)
Georgia (160)
Idaho (21)
Illinois (314)
India (20)
Indiana (170)
Iowa (2)
Japan (132)
Kansas (70)
Kentucky (9)
Louisiana (8)
Maine (45)
Maryland (629)
Massachusetts (3879)
Michigan (97)
Minnesota (220)
Mississippi (1)
Missouri (48)
Montana (18)
Nebraska (9)
Nevada (50)
New Hampshire (49)
New Jersey (1437)
New Mexico (14)
New York (1362)
North Carolina (758)
North Dakota (6)
Northern California (2209)
Ohio (135)
Oklahoma (9)
Oregon (23)
Pennsylvania (1033)
Puerto Rico (9)
Rhode Island (20)
South America (452)
South Carolina (16)
Southern California (1910)
Tennessee (60)
Texas (676)
United States (17928)
Utah (105)
Virginia (112)
Washington D.C. (40)
Washington State (477)
West Virginia (2)
Wisconsin (24)
385,219 Results for "bicycle therapeutics limited".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2025 Financial Results
May 1, 2025
·
10 min read
Press Releases
Bicycle Therapeutics Announces New Board and Key Clinical Leadership Appointments
March 28, 2025
·
9 min read
Press Releases
Bicycle Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
April 1, 2025
·
1 min read
Press Releases
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 5, 2025
May 6, 2025
·
2 min read
Press Releases
Bicycle Therapeutics Announces Presentation of Additional Human Radiopharmaceutical Imaging Data for MT1-MMP at the American Association for Cancer Research Annual Meeting 2025
April 29, 2025
·
7 min read
Press Releases
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 2, 2025
April 3, 2025
·
2 min read
Press Releases
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 5, 2025
·
2 min read
Genetown
Bicycle Therapeutics to Participate in Upcoming June 2024 Investor Conferences
Bicycle Therapeutics plc, a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide technology, announced that management will participate in the following investor conferences in June.
June 3, 2024
·
2 min read
Press Releases
Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2024 Financial Results
February 25, 2025
·
15 min read
Press Releases
Bicycle Therapeutics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
February 5, 2025
·
1 min read
1 of 38,522
Next
